| Financial Ratios | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Return on Equity | -36.849 | - | - | - |
| Net Profit Margin | - | - | -19,570 | -81,425 |
| Debt to Asset Ratio | 17.496 | - | - | - |
| Cash Ratio | 562.5 | - | - | - |
| Quick Ratio | 576.711 | - | - | - |
| Current Ratio | 576.711 | - | - | - |
Cyclacel Pharmaceuticals, Inc. (CYCC)
Cyclacel Pharmaceuticals, Inc. (CYCC)